Total Credits: 2 including 2 AOA Category 1-A Credit(s)
Board Certified in Pain Management
Board Certified in Anesthesia
Medical School—Des Moines University
Anesthesia Residency—Mayo Clinic
Pain Medicine Fellowship—Mayo Clinic
Dr. Smith is a paid consultant for Boston Scientific and Abbott/St. Jude. She is a sub-PI for Medtronic.
Dr. Karry Smith earned a Master of Public Health (MPH) degree and a PhD in Cell Biology from the University of Iowa. She has worked in the pharmaceutical industry since 2014 and is currently a Medical Writing Manager at Greenwich Biosciences, the company that makes the FDA-approved, cannabinoid-based product Epidiolex. In 2019, Dr. Smith earned a graduate certificate in cannabinoid pharmacology from Thomas Jefferson University in Philadelphia.
Dr. Smith has longstanding interests in pain medicine, addiction, opioids, and cannabinoids. To that end, she is currently pursuing a Doctor of Public Health (DrPH) degree at Johns Hopkins in Health Policy and Management and hopes to focus her research on pain and the safety of cannabinoids co-administered with opioids. She is passionate about education and is currently co-teaching a special topics course to healthcare students at Des Moines University that focuses on pain management and associated issues.
Dr. Smith is an employee of Greenwich Biosciences/GW Pharma. She was previously (withing the past 12 months) a paid consultant for MedPharm Iowa, a state-licensed medical cannabis manufacturer.
HIV and PrEP – What effect does this have on the average practitioner? Is it time for all PCPs to learn to care for patients with HIV
Original Program Date: 04/28/2020 |
Please wait ...